Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Hepatology|March 17, 2020
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinomaRobert Montal, Daniela Sia, Carla Montironi, et al.
Gut|February 24, 2022
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classificationCarla Montironi, Florian Castet, Philipp K Haber, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 14, 2023
Tcf20 deficiency is associated with increased liver fibrogenesis and alterations in mitochondrial metabolism in mice and humansBernat Córdoba-Jover, Jordi Ribera, Irene Portolés, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2025
E7386 Enhances Lenvatinib's Antitumor Activity in Preclinical Models and Human Hepatocellular CarcinomaAgavni Mesropian, Albert Gris-Oliver, Ugne Balaseviciute, et al.
Nature Genetics|February 2, 2026
Mutational scanning reveals oncogenic CTNNB1 mutations have diverse effects on signalingAnagha Krishna, Alison Meynert, Karamjit Singh Dolt, et al.
Molecular Cancer Therapeutics|February 13, 2023
Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in HepatoblastomaJordi Abril-Fornaguera, Laura Torrens, Carmen Andreu-Oller, et al.
Gut|August 16, 2018
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trialRoser Pinyol, Robert Montal, Laia Bassaganyas, et al.
Cell Reports. Medicine|April 2, 2026
Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinomaElena Adan-Villaescusa, Borja Castello-Uribe, Iker Uriarte, et al.
Journal of Hepatology|May 16, 2021
Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitisRoser Pinyol, Sara Torrecilla, Huan Wang, et al.
Journal of Hepatology|December 21, 2024
Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinomaSarah Cappuyns, Marta Piqué-Gili, Roger Esteban-Fabró, et al.
Pageof 5